From an earlier post of mine. I think worst cas
Post# of 148107
Quote:
I think worst case scenario there's a 25% mortality rate in SOC and a 10% mortality rate for leronlimab.
The 25% worst case scenario was based on the Dexamethasone's 25% mortality in non-invasive oxygen.
If the 10% (13 patients) is even a bit close there is no way we don't seek approval on interim.